Physician profile
Anthony D Jackson
NPI 1750333944
$3,194.24
in general payments reported to CMS, 2019-2025
29 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $355 · 2021: $341 · 2022: $482 · 2023: $517 · 2024: $596 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,041.37 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $258.07 | 2021-2025 | |
| Hologic Sales and Service, LLC | $216.57 | 2019-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Exeltis, USA INC. | $199.06 | 2019-2025 | Slynd |
| Organon LLC | $182.26 | 2021-2025 | Jada System, Nexplanon |
| Minerva Surgical, INC | $160.90 | 2024 | |
| Roche Diagnostics Corporation | $159.13 | 2019-2021 | |
| Pfizer INC. | $93.61 | 2022-2023 | |
| Astellas Pharma US INC | $85.59 | 2023-2024 | Veozah |
| Sage Therapeutics, LLC | $79.33 | 2024 | |
| Merck Sharp & Dohme LLC | $78.71 | 2020-2024 | Gardasil, Gardasil 9 |
| Agile Therapeutics, INC. | $75.12 | 2021-2023 | Twirla |
| Therapeuticsmd, INC. | $66.30 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.15 | 2019-2020 | |
| Channel Medsystems, INC. | $60.81 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $56.07 | 2019-2021 | |
| Myovant Sciences INC. | $48.91 | 2021-2022 | |
| Allergan, INC. | $44.17 | 2019 | |
| Sumitomo Pharma America, INC. | $40.26 | 2025 | Myfembree |
| Evofem Biosciences, INC. | $35.47 | 2021 | |
| Avion Pharmaceuticals | $31.58 | 2022-2023 | Balcoltra |
| Lupin INC. | $19.09 | 2019 | |
| Exact Sciences Corporation | $16.20 | 2023 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $15.24 | 2024 | Exparel |
| Intuitive Surgical, INC. | $15.05 | 2019 | |
| Axonics, INC. | $14.48 | 2023 | Bulkamid |
| Meditrina | $12.85 | 2025 | |
| Zyla Life Sciences, INC. | $11.55 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.